OSLO (Reuters) -Norway's sovereign wealth fund said on Tuesday it has bought a 95% stake in an office property located along New York City's Avenue of the Americas. Norges Bank Investment Management will pay $542.6 million for the stake, valuing the property at $571.1 million, it added. A unit of Beacon Capital Partners will buy the remaining 5% and manage...

08:33 AM EDT, 09/02/2025 (MT Newswires) -- Editas Medicine ( EDIT ) said Tuesday it has nominated EDIT-401, an LDLR-targeted therapy for hyperlipidemia, as its lead in vivo development candidate. The experimental treatment reduced LDL cholesterol by nearly 90% with a single dose in non-human primates, the company said. EDIT-401 is designed as a one-time gene editing therapy to increase...

08:32 AM EDT, 09/02/2025 (MT Newswires) -- CorMedix ( CRMD ) said Tuesday it has completed the purchase of Melinta Therapeutics. The company paid $300 million in upfront payment, comprised of $260 million in cash and $40 million in Cormediz equity issued to Deerfield Management. The agreement also consists additional regulatory milestone payment of up to $25 million for the...

08:35 AM EDT, 09/02/2025 (MT Newswires) -- Zenas BioPharma ( ZBIO ) and Royalty Pharma ( RPRX ) said Tuesday that the latter will offer up to $300 million in financing in exchange for a royalty on sales of monoclonal antibody obexelimab. Obexelimab is in phase 3 development to treat immunoglobulin G4-related disease (IgG4-RD), and phase 2 development for relapsing...